• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因供水污染继发的急性流行性铝中毒性骨软化症

Acute epidemic aluminium osteomalacia secondary to water supply contamination.

作者信息

O'Brien A A, Moore D P, Keogh J A

机构信息

Department of Clinical Medicine, Meath Hospital, Dublin.

出版信息

Ir J Med Sci. 1990 Mar;159(3):71-3. doi: 10.1007/BF02946671.

DOI:10.1007/BF02946671
PMID:2361822
Abstract

When the aluminium content of the water supply to our Haemodialysis Unit rose from less than 0.5 mumol/l to 6 mumol/l over a two month period, we carried out bone biopsies and desferrioxamine infusion tests on twelve (12) patients who had been on haemodialysis for less than one year (mean 8 months) and had normal serum aluminium levels. The patients had no bone symptoms. Eight patients had positive aluminium bone stains. The aluminium osteomalacia group (n = 8) had a mean PTH of 1.4 ng/ml s.e. 0.3 whereas the non-ALO group had a mean PTH of 2.9 ng/ml s.e. 0.7. The difference in mean PTH is significant (p less than 0.05). There was no evidence of encephalopathy, fractures or microcytic anaemia in the ALO positive group. The aluminium contamination of the water supply occurred because of a change in the reservoir purification system from sand-filtration to alum.

摘要

在两个月的时间里,我们血液透析单元的供水铝含量从低于0.5微摩尔/升升至6微摩尔/升,于是我们对12名血液透析时间不到一年(平均8个月)且血清铝水平正常的患者进行了骨活检和去铁胺输注试验。这些患者没有骨骼症状。8名患者的铝骨染色呈阳性。铝骨软化症组(n = 8)的甲状旁腺激素(PTH)平均水平为1.4纳克/毫升,标准误为0.3,而非铝骨软化症组的PTH平均水平为2.9纳克/毫升,标准误为0.7。PTH平均水平的差异具有统计学意义(p小于0.05)。铝骨软化症阳性组没有出现脑病、骨折或小细胞性贫血的迹象。供水受到铝污染是因为蓄水池净化系统从砂滤改为了明矾。

相似文献

1
Acute epidemic aluminium osteomalacia secondary to water supply contamination.因供水污染继发的急性流行性铝中毒性骨软化症
Ir J Med Sci. 1990 Mar;159(3):71-3. doi: 10.1007/BF02946671.
2
Aluminium osteomalacia in chronic renal failure patients neither on dialysis nor taking aluminium containing phosphate binders.
Ir J Med Sci. 1990 Mar;159(3):74-6. doi: 10.1007/BF02946672.
3
Dialysate aluminium concentration and renal bone disease.透析液铝浓度与肾性骨病
Kidney Int. 1982 Feb;21(2):411-5. doi: 10.1038/ki.1982.37.
4
Aluminium-related osteomalacia: response to reverse osmosis water treatment.铝相关性骨软化症:对反渗透水处理的反应
Kidney Int. 1987 Jul;32(1):96-101. doi: 10.1038/ki.1987.177.
5
Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium.
Lancet. 1978 Apr 22;1(8069):841-5. doi: 10.1016/s0140-6736(78)90191-5.
6
Quantitative bone scanning in the diagnosis of aluminium osteomalacia.
Nephrol Dial Transplant. 1989;4(8):721-4. doi: 10.1093/ndt/4.8.721.
7
Serum aluminium concentration and aluminium deposits in bone in patients receiving haemodialysis.接受血液透析患者的血清铝浓度及骨内铝沉积
Br Med J (Clin Res Ed). 1985 Jun 1;290(6482):1613-4. doi: 10.1136/bmj.290.6482.1613.
8
Haemodialysis related osteomalacia: a staining method to demonstrate aluminium.血液透析相关骨软化症:一种显示铝的染色方法。
J Clin Pathol. 1981 Dec;34(12):1352-4. doi: 10.1136/jcp.34.12.1352.
9
[The role of aluminum in the development of osteomalacia in patients on chronic hemodialysis].[铝在慢性血液透析患者骨软化症发生中的作用]
Pol Arch Med Wewn. 1988 Jan;79(1):3-12.
10
Aluminum - related osteomalacia.铝相关性骨软化症
Int J Artif Organs. 1983 Jul;6(4):173-5.

本文引用的文献

1
A modification of the masson trichrome technique for routine laboratory purposes.一种用于常规实验室目的的改良马森三色染色技术。
Am J Pathol. 1938 Mar;14(2):237-43.
2
Treatment of fracturing renal osteodystrophy by desferrioxamine.
Proc Eur Dial Transplant Assoc. 1983;19:203-7.
3
Quantitative bone histology in 84 normal American subjects. Micromorphometric analysis and evaluation of variance in iliac bone.84名正常美国受试者的定量骨组织学。髂骨的微观形态计量分析及方差评估。
Calcif Tissue Int. 1982 Sep;34(5):449-55. doi: 10.1007/BF02411283.
4
Osteomalacia in patients with chronic renal failure before dialysis or transplantation.
Q J Med. 1983 Summer;52(207):332-48.
5
Aluminium hydroxide intake: real risk of aluminium toxicity.氢氧化铝摄入:铝中毒的实际风险。
Br Med J (Clin Res Ed). 1983 Jun 18;286(6382):1937-8. doi: 10.1136/bmj.286.6382.1937-a.
6
The efficacy of various treatment modalities on aluminium associated bone disease.
Proc Eur Dial Transplant Assoc. 1983;19:195-202.
7
Suppression of parathyroid hormone secretion by aluminum.铝对甲状旁腺激素分泌的抑制作用。
Kidney Int. 1983 May;23(5):699-704. doi: 10.1038/ki.1983.81.
8
Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy.去铁胺输注试验在铝相关性骨营养不良诊断中的应用。
Ann Intern Med. 1984 Dec;101(6):775-9. doi: 10.7326/0003-4819-101-6-775.
9
Haemodialysis related osteomalacia: a staining method to demonstrate aluminium.血液透析相关骨软化症:一种显示铝的染色方法。
J Clin Pathol. 1981 Dec;34(12):1352-4. doi: 10.1136/jcp.34.12.1352.
10
Hyperaluminaemia from aluminum resins in renal failure.肾衰竭患者因铝树脂导致的高铝血症。
Lancet. 1970 Sep 5;2(7671):494-6. doi: 10.1016/s0140-6736(70)90113-3.